Novartis to acquire Xiidra in a $5.3B deal

Japan |  News | 0 Comment | 10 May, 2019

Novartis announced that it has entered into an agreement with Takeda Pharmaceutical Company Limited to acquire the assets associated with Xiidra® (lifitegrast ophthalmic solution) ...Read more

Promethera Biosciences makes progress in HepaStem development programme

Japan |  News | 0 Comment | 09 May, 2019

Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, has announced the dosing of a first patient in a Phase 2a clinical study for the company’s He...Read more

Promethera Biosciences completes €39.7 M Series D Financing

Japan |  News | 0 Comment | 08 May, 2019

Promethera Biosciences, a global innovator in cell-based medicines and liver diseases has announced the closing of a €39.7 million (JPY4.94 billion) Series D financing. The round...Read more

Daiichi Sankyo- AstraZeneca’s breast cancer drug reveals positive response

Japan |  News | 0 Comment | 08 May, 2019

Daiichi Sankyo Company, Limited (Daiichi Sankyo) and AstraZeneca have announced positive topline results for the pivotal phase 2 DESTINY-Breast01 trial of [fam-] trastuzumab deruxtecan (DS-...Read more

Eisai with UK DRI launches new Post-Doctoral programme

Japan |  News | 0 Comment | 08 May, 2019

Eisai Co., Ltd. and the UK Dementia Research Institute (UK DRI) announced the launch of a joint post-doctoral programme to support the advancement of novel dementia research. This first-of-...Read more

Takeda collaborates with Skyhawk to develop solutions for neurodegenerative diseases

Japan |  News | 0 Comment | 07 May, 2019

US based Skyhawk Therapeutics, Inc. has announced a strategic collaboration with Japan headquartered Takeda Pharmaceutical Company Limited in which Skyhawk will use its SkySTAR™techno...Read more

Takeda opens new global research center in San Diego

Japan |  News | 0 Comment | 03 May, 2019

Takeda has announced the opening of a new research facility in San Diego, California. Extending Takeda’s 14-year presence in San Diego, the 165,000-square-foot facility is home to mor...Read more

Takeda announces Andrey Potapov as ICMEA Area Head

Japan |  News | 0 Comment | 30 Apr, 2019

Global biopharmaceutical company Takeda announced Andrey Potapov as its Area Head for India, CIS (the Commonwealth of Independent States), the Middle East including Turkey, and Africa (ICME...Read more

Japanese scientists reveal potential of technology to detect cancer

Japan |  News | 0 Comment | 29 Apr, 2019

Researchers at Okayama University in Japan have reported in the journal Sensors and Actuators B: Chemical that terahertz radiation can be used to rapidly detect makers for breast-cancer cel...Read more

Santen, Glaukos collaborate for exclusive distribution of the MicroShunt in the U.S.

Japan |  News | 0 Comment | 26 Apr, 2019

Santen and Glaukos have announced that Santen’s U.S. subsidiary, Santen Inc., has entered into a multi-year agreement whereby Glaukos will become the exclusive distributor of the Micr...Read more

Daiichi selects oncology candidate built on Zymeworks’ Bispecific platform

Japan |  News | 0 Comment | 26 Apr, 2019

Zymeworks Inc. a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, and Daiichi Sankyo Company, Limited (“Daiichi Sankyo”) announced that, the ...Read more

Daiichi Sankyo sells Its Nihonbashi building in Japan

Japan |  News | 0 Comment | 26 Apr, 2019

Daiichi Sankyo Company LTD. (Daiichi Sankyo), dedicated to the creation and supply of innovative pharmaceutical products, announced that it has sold its wholly owned Nihonbashi Building loc...Read more

Salix partners with Mitsubishi Tanabe Pharma to market IBD drug

Japan |  News | 0 Comment | 26 Apr, 2019

Salix Pharmaceuticals ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases, and a wholly owne...Read more

Velabs collaborates with Chiome for GPCR-Specific functional antibody screening

Japan |  News | 0 Comment | 24 Apr, 2019

Velabs Therapeutics, specializing in the fast generation of functional therapeutic antibodies, announced that it has entered into an agreement with Chiome Bioscience, Inc., Tokyo, to jointl...Read more

LifeArc licenses lead stage molecules to Daiichi Sankyo

Japan |  News | 0 Comment | 24 Apr, 2019

LifeArc, one of the UK’s leading medical research charities, has signed a deal to license an ion channel drug discovery programme to Daiichi Sankyo Company, Limited. Small molecules,...Read more

Eisai selected as a Competitive IT Strategy Company 2019

Japan |  News | 0 Comment | 24 Apr, 2019

Eisai Co has been selected by the Ministry of Economy, Trade and Industry (METI) and the Tokyo Stock Exchange (TSE) as a Competitive IT Strategy Company 2019 as a company that is engag...Read more

ACT Genomics to provide cancer genomic profiling service

Japan |  News | 0 Comment | 21 Apr, 2019

ACTmed, a joint venture between Canon Medical Systems Corporation and ACT Genomics, has established an analysis laboratory named "Shonan iPark Laboratory" in "Shonan Health Innovation Park"...Read more

Nagasaki University, NEC initiate program on Global Health

Japan |  News | 0 Comment | 18 Apr, 2019

Nagasaki University and NEC Corporation have established a program on global health & biometric authentication with Nagasaki University's Graduate School of Tropical Medicine and Global...Read more